Home > Protocol Summaries: Compounds > cetirizine

Protocol Summaries: cetirizine

Protocol Summaries for cetirizine
GSK
Study ID		 Phase Title Status
104912 Phase 3 Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering from Perennial Allergic Rhinitis- Completed
104913 Phase 3 Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering from Atopic Dermatitis- Completed
104914 Phase 3 Long-term Study of Cetirizine Dry Syrup in Children. Suffering from Perennial Allergic Rhinitis. Completed
104915 Phase 3 Long-term Study of Cetirizine Dry Syrup in Children suffering from Various Type of Cutaneous Disease Accompanied with Pruritus. Completed
110458 Phase 3 A randomized, double blind, placebo controlled study for evaluation of the efficacy and safety of cetirizine dry syrup (CTZ DS) (2.5 mg or 5 mg twice a day) in children (2 years of age or older but under 15 years old) suffering from perennial allergic rhinitis. Completed

Filter list by: